Laboratório de Pesquisa em Infectologia, Complexo Hospitalar Universitário Professor Edgard Santos, Universidade Federal da Bahia (UFBA), Salvador, BA, Brazil.
Braz J Infect Dis. 2013 Nov-Dec;17(6):661-6. doi: 10.1016/j.bjid.2013.04.009. Epub 2013 Sep 9.
The human retroviruses HIV-1 and HTLV-1 share the routes of infection with hepatitis viruses B and C. Co-infection by these agents are a common event, but we have scarce knowledge on co-infection by two or more of these agents.
To evaluate the characteristics and risk factors for co-infections by HBV and HCV in patients infected by HIV-1 or/and HTLV-1, in Salvador, Brazil.
In a case-control study we evaluated patients followed in the AIDS and HTLV clinics of Federal University of Bahia Hospital. Clinical and epidemiological characteristics were reviewed, and patients were tested for the presence of serological markers of HBV and HCV infections. HCV-infected patients were tested by PCR to evaluate the presence of viremia.
A total of 200 HIV-1, 213 HTLV-1-infected, and 38 HIV-HTLV-co-infected individuals were included. HIV-infected patients were more likely to have had more sexual partners in the lifetime than other patients' groups. HIV-HTLV-co-infected subjects were predominantly male. Patients infected by HTLV or co-infected had a significantly higher frequency of previous syphilis or gonorrhea, while HIV infection was mainly associated with HPV infection. Co-infection was significantly associated to intravenous drug use (IVDU). HBV and/or HCV markers were more frequently found among co-infected patients. HBV markers were more frequently detected among HIV-infected patients, while HCV was clearly associated with IVDU across all groups. AgHBs was strongly associated with co-infection by HIV-HTLV (OR=22.03, 95% CI: 2.69-469.7), as well as confirmed HCV infection (p=0.001). Concomitant HCV and HBV infection was also associated with retroviral co-infection. Patients infected by HTLV-1 had a lower chance of detectable HCV viremia (OR=0.04, 95% CI: 0.002-0.85).
Infection by HCV and/or HBV is frequent among patients presenting retroviral infection, but risk factors and prevalence for each infection are distinct for each agent. Retroviral co-infection increases the risk of a positive AgHBs, but HTLV-1 infection seems to increase the likelihood of HCV spontaneous clearance.
人类逆转录病毒 HIV-1 和 HTLV-1 与乙型肝炎病毒和丙型肝炎病毒的感染途径相同。这些病原体的合并感染很常见,但我们对两种或更多种病原体合并感染的了解甚少。
评估巴西萨尔瓦多感染 HIV-1 或/和 HTLV-1 的患者中乙型肝炎病毒和丙型肝炎病毒合并感染的特征和危险因素。
我们在联邦大学巴伊亚医院的艾滋病和 HTLV 诊所进行了病例对照研究,对患者进行了临床和流行病学特征回顾,并检测了乙型肝炎病毒和丙型肝炎病毒感染的血清学标志物。丙型肝炎病毒感染患者通过 PCR 检测病毒血症。
共纳入 200 例 HIV-1 感染者、213 例 HTLV-1 感染者和 38 例 HIV-HTLV 合并感染者。HIV 感染者一生中发生性行为的伴侣数量明显多于其他两组患者。HIV-HTLV 合并感染者以男性为主。感染 HTLV 或合并感染的患者既往梅毒或淋病感染率明显较高,而 HIV 感染主要与 HPV 感染相关。合并感染与静脉吸毒(IDU)显著相关。合并感染者 HBV 和/或 HCV 标志物的检出率较高。HBV 标志物在 HIV 感染者中更为常见,而 HCV 则在所有组中与 IDU 明显相关。抗-HBs 与 HIV-HTLV 合并感染(OR=22.03,95%CI:2.69-469.7)和丙型肝炎病毒确诊感染(p=0.001)显著相关。同时感染 HCV 和 HBV 也与逆转录病毒合并感染相关。感染 HTLV-1 的患者检测到 HCV 病毒血症的可能性较低(OR=0.04,95%CI:0.002-0.85)。
感染 HCV 和/或 HBV 在感染逆转录病毒的患者中很常见,但每种感染的危险因素和流行率因每种病原体而异。逆转录病毒合并感染增加抗-HBs 阳性的风险,但 HTLV-1 感染似乎增加了 HCV 自发清除的可能性。